Our laboratory is proud to offer Pre-Implantation Genetic Diagnosis with Fluorescent In Situ Hybridization to test embryos for some chromosomal abnormalities, X-linked diseases and sex selection for family balancing prior to embryo transfer. 

 As maternal age increases, the incidence of chromosomal abnormalities rises resulting in decreased fertility and increased risk of spontaneous pregnancy loss and live born infants with chromosomal abnormalities such as Downs Syndrome.  This treatment allows the laboratory to remove embryos containing certain numerical chromosomal defects (aneuploidy) from the pool of embryos available for transfer.  There is preliminary evidence to suggest that aneuploidy screening in certain couples may improve the success of IVF by selecting embryos which possibly have both an improved potential for implantation and a decreased rate of spontaneous loss while also decreasing the chance of a live born child with chromosomal abnormalities.

 The eight chromosomes tested are 13, 15, 16, 18, 21, 22, X and Y.   Though technically demanding, the testing has a low error rate approximated at 2% to 5% by current data.